Strategic application of liposomal system to R-α-lipoic acid for the improvement of nutraceutical properties

References

• Bjorklund G, Aaseth J, Crisponi G, et al. Insights on alpha lipoic and dihydrolipoic acids as promising scavengers of oxidative stress and possible chelators in mercury toxicology. J Inorg Biochem. 2019;195:111–119.
   PubMed Web of Science ®Google Scholar
• Moura FA, de Andrade KQ, dos Santos JC, et al. Lipoic acid: its antioxidant and anti-inflammatory role and clinical applications. Curr Top Med Chem. 2015;15(5):458–483.
   PubMed Web of Science ®Google Scholar
• Li YX, Park EY, Lim ST. Stabilization of alpha-lipoic acid by complex formation with octenylsuccinylated high amylose starch. Food Chem. 2018;242:389–394.
   PubMed Web of Science ®Google Scholar
• Shay KP, Moreau RF, Smith EJ, et al. Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential. Biochim Biophys Acta. 2009;1790(10):1149–1160.
   PubMed Web of Science ®Google Scholar
• Moini H, Packer L, Saris NE. Antioxidant and prooxidant activities of alpha-lipoic acid and dihydrolipoic acid. Toxicol Appl Pharmacol. 2002;182(1):84–90.
   PubMed Web of Science ®Google Scholar
• Ikuta N, Okamoto H, Furune T, et al. Bioavailability of an R-alpha-lipoic acid/gamma-cyclodextrin complex in healthy volunteers. Int J Mol Sci. 2016;17(6):949.
   Web of Science ®Google Scholar
• Ikuta N, Sugiyama H, Shimosegawa H, et al. Analysis of the enhanced stability of r(+)-alpha lipoic acid by the complex formation with cyclodextrins. Int J Mol Sci. 2013;14(2):3639–3655.
   PubMed Web of Science ®Google Scholar
• Park CH, Lee J. pH-dependent sustained release characteristics of disulfide polymers prepared by simple thermal polymerization. J Biomater Sci Polym Ed. 2013;24(16):1848–1857.
   PubMed Web of Science ®Google Scholar
• El-Say KM, Ahmed OA, Mohamed AI, et al. Zein-alpha lipoic acid-loaded nanoparticles to enhance the oral bioavailability of dapoxetine: optimization and clinical pharmacokinetic evaluation. Int J Nanomedicine. 2019;14:7461–7473.
   PubMed Web of Science ®Google Scholar
• Huang J, Wang Q, Li T, et al. Multilayer emulsions as a strategy for linseed oil and alpha-lipoic acid micro-encapsulation: study on preparation and in vitro characterization. J Sci Food Agric. 2018;98(9):3513–3523.
   PubMed Web of Science ®Google Scholar
• Pecora TM, Musumeci T, Musumeci L, et al. Evaluation of Eudragit(R) retard polymers for the microencapsulation of alpha-lipoic acid. Curr Drug Deliv. 2016;13(7):1165–1175.
   PubMed Web of Science ®Google Scholar
• Li YX, Kim YJ, Reddy CK, et al. Enhanced bioavailability of alpha-lipoic acid by complex formation with octenylsuccinylated high-amylose starch. Carbohydr Polym. 2019;219:39–45.
   PubMed Web of Science ®Google Scholar
• Dolinina ES, Akimsheva EY, Parfenyuk EV. Development of novel silica-based formulation of alpha-lipoic acid: evaluation of photo and thermal stability of the encapsulated drug. Pharmaceutics. 2020;12(3):228.
   Web of Science ®Google Scholar
• Ursino MG, Poluzzi E, Caramella C, et al. Excipients in medicinal products used in gastroenterology as a possible cause of side effects. Regul Toxicol Pharmacol. 2011;60(1):93–105.
   PubMed Web of Science ®Google Scholar
• Lee MK. Liposomes for enhanced bioavailability of water-insoluble drugs: in vivo evidence and recent approaches. Pharmaceutics. 2020;12(3):264.
   PubMed Web of Science ®Google Scholar
• Schroeder A, Avnir Y, Weisman S, et al. Controlling liposomal drug release with low frequency ultrasound: mechanism and feasibility. Langmuir. 2007;23(7):4019–4025.
   PubMed Web of Science ®Google Scholar
• Lombardo D, Kiselev MA. Methods of liposomes preparation: formation and control factors of versatile nanocarriers for biomedical and nanomedicine application. Pharmaceutics. 2022;14(3):543.
   PubMed Web of Science ®Google Scholar
• Onoue S, Yamamoto K, Kawabata Y, et al. In vitro/in vivo characterization of nanocrystalline formulation of Tranilast with improved dissolution and hepatoprotective properties. Eur J Pharm Biopharm. 2013;85(3 Pt B):952–957.
   PubMed Web of Science ®Google Scholar
• Bergmeyer HU, Scheibe P, Wahlefeld AW. Optimization of methods for aspartate aminotransferase and alanine aminotransferase. Clin Chem. 1978;24(1):58–73.
   PubMed Web of Science ®Google Scholar
• Li Z, Zhang M, Liu C, et al. Development of liposome containing sodium deoxycholate to enhance oral bioavailability of itraconazole. Asian J Pharm Sci. 2017;12(2):157–164.
   PubMed Web of Science ®Google Scholar
• Serrano G, Almudever P, Serrano JM, et al. Phosphatidylcholine liposomes as carriers to improve topical ascorbic acid treatment of skin disorders. Clin Cosmet Investig Dermatol. 2015;8:591–599.
   PubMed Web of Science ®Google Scholar
• Takeuchi H, Yamamoto H, Kawashima Y. Mucoadhesive nanoparticulate systems for peptide drug delivery. Adv Drug Deliv Rev. 2001;47(1):39–54.
   PubMed Web of Science ®Google Scholar
• Takeuchi H, Matsui Y, Sugihara H, et al. Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs. Int J Pharm. 2005;303(1–2):160–170.
   PubMed Web of Science ®Google Scholar
• Li Y, Yuan J, Yang Q, et al. Immunoliposome co-delivery of bufalin and anti-CD40 antibody adjuvant induces synergetic therapeutic efficacy against melanoma. Int J Nanomed. 2014;9:5683–5700.
   PubMed Web of Science ®Google Scholar
• Bachrach SM, Woody JT, Mulhearn DC. Effect of ring strain on the thiolate-disulfide exchange. a computational study. J Org Chem. 2002;67(25):8983–8990.
   PubMed Web of Science ®Google Scholar
• Jash A, Ubeyitogullari A, Rizvi SSH. Liposomes for oral delivery of protein and peptide-based therapeutics: challenges, formulation strategies, and advances. J Mater Chem B. 2021;9(24):4773–4792.
   PubMed Web of Science ®Google Scholar
• He H, Lu Y, Qi J, et al. Adapting liposomes for oral drug delivery. Acta Pharm Sin B. 2019;9(1):36–48.
   PubMed Web of Science ®Google Scholar
• Zhao M, Lee SH, Song JG, et al. Enhanced oral absorption of sorafenib via the layer-by-layer deposition of a pH-sensitive polymer and glycol chitosan on the liposome. Int J Pharm. 2018;544(1):14–20.
   PubMed Web of Science ®Google Scholar
• Mu H, Holm R, Mullertz A. Lipid-based formulations for oral administration of poorly water-soluble drugs. Int J Pharm. 2013;453(1):215–224.
   PubMed Web of Science ®Google Scholar
• Rochette L, Ghibu S, Muresan A, et al. Alpha-lipoic acid: molecular mechanisms and therapeutic potential in diabetes. Can J Physiol Pharmacol. 2015;93(12):1021–1027.
   PubMed Web of Science ®Google Scholar
• Goeptar AR, Scheerens H, Vermeulen NP. Oxygen and xenobiotic reductase activities of cytochrome P450. Crit Rev Toxicol. 1995;25(1):25–65.
   PubMed Web of Science ®Google Scholar
• Clawson GA. Mechanisms of carbon tetrachloride hepatotoxicity. Pathol Immunopathol Res. 1989;8(2):104–112.
   PubMedGoogle Scholar
• Friedman SL. Evolving challenges in hepatic fibrosis. Nat Rev Gastroenterol Hepatol. 2010;7(8):425–436.
   PubMed Web of Science ®Google Scholar
• Castaneda-Arriaga R, Alvarez-Idaboy JR. Lipoic acid and dihydrolipoic acid. A comprehensive theoretical study of their antioxidant activity supported by available experimental kinetic data. J Chem Inf Model. 2014;54(6):1642–1652.
   PubMed Web of Science ®Google Scholar
• Sadek KM, Saleh EA, Nasr SM. Molecular hepatoprotective effects of lipoic acid against carbon tetrachloride-induced liver fibrosis in rats: hepatoprotection at molecular level. Hum Exp Toxicol. 2018;37(2):142–154.
   PubMed Web of Science ®Google Scholar